Azuma Kanatsuka

3.3k citations

107 papers · 2.6k indexed · h-index 26

Endocrinology, Diabetes and Metabolism top 0.5%
Surgery top 2%
Genetics top 2%
Molecular Biology top 10%
Physiology top 5%

Co-authors: Hideichi Makino Sho Yoshida T. Yamaguchi Yoshiharu Tokuyama Haruhiko Ohsawa Tetsuro Kobayashi Akira Shimada Ikki Shimizu
Topics: Pancreatic function and diabetes (54 papers)Diabetes Treatment and Management (32 papers)Diabetes Management and Research (30 papers)
Cited by: Endocrinology, Diabetes and Metabolism Endocrine and Autonomic Systems Genetics
Journals: Science The Journal of Clinical Endocrinology & Metabolism Diabetes Care
Partner nations: Japan United States Germany

In The Last Decade

Azuma Kanatsuka

103 papers receiving 2.5k citations

Peers

Countries citing papers authored by Azuma Kanatsuka

Since Specialization

Citations

This map shows the geographic impact of Azuma Kanatsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Azuma Kanatsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Azuma Kanatsuka more than expected).

Fields of papers citing papers by Azuma Kanatsuka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Azuma Kanatsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Azuma Kanatsuka. The network helps show where Azuma Kanatsuka may publish in the future.

Co-authorship network of co-authors of Azuma Kanatsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Azuma Kanatsuka. A scholar is included among the top collaborators of Azuma Kanatsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Azuma Kanatsuka. Azuma Kanatsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of a SNP in the IAPP gene and hyperglycemia on β-cell dysfunction in type 2 diabetes: the Toon Genome Study 2021 ·Diabetology International ·Ryoichi Kawamura,Yasuharu Tabara,Yasunori Takata,Koutatsu Maruyama,(unknown),(unknown),Yumi Matsushita,(unknown),Hideichi Makino,Isao Saito,Azuma Kanatsuka,Haruhiko Osawa	2
2	IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetes 2018 ·Diabetology International ·Azuma Kanatsuka,(unknown),Hideichi Makino	43
3	Abdominal Induration Caused by Repeated Same Site Insulin Injections is Related to the HbA1c Level and Diurnal Fasting Blood Glucose Variation in Type 2 Diabetics 2015 ·Aya Ishii,(unknown),(unknown),Azuma Kanatsuka	2
4	Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in Japan (JDDM32) 2013 ·Journal of Diabetes Investigation ·Mariko Oishi,Katsuya Yamazaki,FUMINOBU OKUGUCHI,Hidekatsu Sugimoto,Azuma Kanatsuka,Atsunori Kashiwagi	80
5	Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus 2008 ·Annals of Medicine ·Hiroko Takaike,Yasuko Uchigata,Yasuhiko Iwamoto,Akihisa Imagawa,Hiromi Iwahashi,Azuma Kanatsuka,Eiji Kawasaki,Tetsuro Kobayashi,Akira Shimada,Ikki Shimizu,Taro Maruyama,Toshiaki Hanafusa,Hideichi Makino	10
6	Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes 2008 ·Diabetes Research and Clinical Practice ·Akihisa Imagawa,Toshiaki Hanafusa,Hiromi Iwahashi,Yasuko Uchigata,Azuma Kanatsuka,Eiji Kawasaki,Tetsuro Kobayashi,Akira Shimada,Ikki Shimizu,Taro Maruyama,Hideichi Makino	13
7	Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy—a nationwide 5-year-study in Japan 2007 ·Diabetologia ·Yoshio MURASE,Akihisa Imagawa,Toshiaki Hanafusa,Hiromi Iwahashi,Yasuko Uchigata,Azuma Kanatsuka,Eiji Kawasaki,Tetsuro Kobayashi,Akira Shimada,Ikki Shimizu,Taro Maruyama,Hideichi Makino	27
8	Clinical and Immunogenetic Characteristics of Fulminant Type 1 Diabetes Associated with Pregnancy 2006 ·The Journal of Clinical Endocrinology & Metabolism ·Ikki Shimizu,Hideichi Makino,Akihisa Imagawa,Hiromi Iwahashi,Yasuko Uchigata,Azuma Kanatsuka,Eiji Kawasaki,Tetsuro Kobayashi,Akira Shimada,Taro Maruyama,Toshiaki Hanafusa	3
9	Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus 2005 ·Diabetologia ·Akihisa Imagawa,Toshiaki Hanafusa,Yasuko Uchigata,Azuma Kanatsuka,Eiji Kawasaki,Tetsuro Kobayashi,Akira Shimada,Ikki Shimizu,Taro Maruyama,Hideichi Makino	92
10	Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis 2004 ·Metabolism ·Yuriko Yoshida,Naotake Hashimoto,Yoshiharu Tokuyama,Hiroshi Kitagawa,Kazuo Takahashi,Kazuo Yagui,Azuma Kanatsuka,Hideaki Bujo,(unknown),(unknown),Shouji Yoshida,Yasushi Saitō	10
11	Multicenter Prevention Trial of Slowly Progressive Type 1 Diabetes with Small Dose of Insulin (the Tokyo Study) 2003 ·Annals of the New York Academy of Sciences ·Taro Maruyama,Akira Shimada,Azuma Kanatsuka,Akira Kasuga,Izumi Takei,Junichi Yokoyama,Tetsuro Kobayashi	37
12	Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic β cells 1999 ·Metabolism ·(unknown),Kazuo Yagui,Yoshiharu Tokuyama,Katsumi Yamada,Yoshifumi Suzuki,Jun‐ichi Miyazaki,Naotake Hashimoto,Hideichi Makino,Yasushi Saitō,Azuma Kanatsuka	51
13	Effect of ACE gene on diabetic nephropathy in NIDDM patients with insulin resistance 1999 ·American Journal of Kidney Diseases ·(unknown),Takashi Iizuka,Hiroko Itô,Kazuo Yagui,Masao Omura,Osamu Nozaki,Tetsuo Nishikawa,Hiroki Tsuchida,Hideichi Makino,Yasushi Saitō,Azuma Kanatsuka	17
14	Expression of human islet amyloid polypeptide/amylin impairs insulin secretion in mouse pancreatic β cells 1997 ·Metabolism ·(unknown),Kazuo Yagui,T. Yamaguchi,(unknown),(unknown),F Shimada,Jun‐ichi Miyazaki,Hiroshi Horie,Yasushi Saitō,Hideichi Makino,Azuma Kanatsuka	22
15	Identification of two novel amino acid polymorphisms in beta-cell/liver (GLUT2) glucose transporter in Japanese subjects 1995 ·Diabetologia ·F Shimada,Hideichi Makino,(unknown),Shigeki Miyamoto,Naotake Hashimoto,Azuma Kanatsuka,Graeme I. Bell,Sho Yoshida	11
16	Type 2 (non-insulin-dependent) diabetes mellitus associated with a mutation of the glucokinase gene in a Japanese family 1993 ·Diabetologia ·F Shimada,Hideichi Makino,Naotake Hashimoto,M. Taira,Susumu Seino,Graeme I. Bell,Azuma Kanatsuka,S. Yoshida	37
17	Islet amyliod polypeptide-derived amyloid deposition increases along with the duration of type 2 diabetes mellitus 1992 ·Diabetes Research and Clinical Practice ·Haruhiko Ohsawa,Azuma Kanatsuka,(unknown),Yoshiharu Tokuyama,(unknown),Atsuo Mikata,Hideichi Makino,(unknown)	17
18	Amyloid protein in somatostatinoma differs from human islet amyloid polypeptide 1991 ·European Journal of Endocrinology ·Haruhiko Ohsawa,Azuma Kanatsuka,Yoshiharu Tokuyama,T. Yamaguchi,(unknown),Sho Yoshida,Hiroshi Horie,(unknown),(unknown)	9
19	Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets 1989 ·Biochemical and Biophysical Research Communications ·Haruhiko Ohsawa,Azuma Kanatsuka,T. Yamaguchi,Hideichi Makino,Sho Yoshida	158
20	Dual Mechanism Involved in the Hydrolysis of Polyphosphoinositides in Rat Pancreatic Islets 1989 ·Endocrinology ·T. Yamaguchi,Azuma Kanatsuka,Hideichi Makino,Haruhiko Ohsawa,Sho Yoshida	9

About Azuma Kanatsuka

Azuma Kanatsuka is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics, having authored 107 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (54 papers), Diabetes Treatment and Management (32 papers) and Diabetes Management and Research (30 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Endocrine and Autonomic Systems (238 citations) and Genetics (860 citations). Azuma Kanatsuka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hideichi Makino, Sho Yoshida, T. Yamaguchi, Yoshiharu Tokuyama, Haruhiko Ohsawa, Tetsuro Kobayashi, Akira Shimada, Ikki Shimizu, Naotake Hashimoto and Taro Maruyama. Their work appears in journals such as Science, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact